Kristian Winge

researcher

Born 2000-01-01

Kristian Winge is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0001-8354-9143

P108employerOdense University HospitalQ2496415
Bispebjerg HospitalQ3374802
Zealand University HospitalQ12333823
Novo Nordisk FondenQ22723716
P735given nameKristianQ12794332
KristianQ12794332
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q52147948Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
Q84591717Anal sphincter EMG in the diagnosis of parkinsonian syndromes
Q37419121Assessment of brain reference genes for RT-qPCR studies in neurodegenerative diseases
Q33776552Autoimmune antibody decline in Parkinson's disease and Multiple System Atrophy; a step towards immunotherapeutic strategies.
Q36434541Bladder dysfunction in Parkinsonism: mechanisms, prevalence, symptoms, and management.
Q44925060Bladder dysfunction in advanced Parkinson's disease.
Q58614424Cerebrospinal fluid pro-inflammatory cytokines differentiate parkinsonian syndromes
Q50226411Challenges in the differential diagnoses of parkinsonism
Q42469354Changes in total cell numbers of the basal ganglia in patients with multiple system atrophy - A stereological study
Q38773862Clinical Features in a Danish Population-Based Cohort of Probable Multiple System Atrophy Patients
Q42512726Cytokine profiling in the prefrontal cortex of Parkinson's Disease and Multiple System Atrophy patients
Q45070107Effects of dopaminergic treatment on bladder function in Parkinson's disease.
Q50450975Effects of progressive resistance exercise in akinetic-rigid Parkinson's disease patients: a randomized controlled trial.
Q57649440Effects of supervised slackline training on postural instability, freezing of gait, and falls efficacy in people with Parkinson’s disease
Q38871946Evaluating Outcomes for Older Patients with Parkinson's Disease or Dementia with Lewy Bodies who have been Hospitalised for Hip Fracture Surgery: Potential Impact of Drug Administration
Q38486351Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative.
Q92255972Increased prefrontal cortex interleukin-2 protein levels and shift in the peripheral T cell population in progressive supranuclear palsy patients
Q38499744Lower urinary tract dysfunction in patients with parkinsonism and other neurodegenerative disorders
Q48354723Lower urinary tract symptoms and bladder control in advanced Parkinson's disease: effects of deep brain stimulation in the subthalamic nucleus
Q39014274Lower urinary tract symptoms in Parkinson's disease: Prevalence, aetiology and management.
Q50563200Lumbar puncture headache. Routines of Danish hospital departments compared with recommendations found in the literature
Q40434824Neocortical Neuronal Loss in Patients with Multiple System Atrophy: A Stereological Study.
Q45152977Oxysterols and Parkinson's disease: evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease.
Q64778253Photobiomodulation in Parkinson's disease: A randomized controlled trial
Q44593037Prevalence of bladder dysfunction in Parkinsons disease.
Q34486230Quetiapine versus aripiprazole in children and adolescents with psychosis--protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trial
Q85653930Repeated treatments of drooling with botulinum toxin B in neurology
Q83889634The DJ-1 concentration in cerebrospinal fluid does not differentiate among Parkinsonian syndromes
Q64787894The biomarker potential of cell-free microRNA from cerebrospinal fluid in Parkinsonian Syndromes
Q87636882The influence of preanalytical conditions on the DJ-1 concentration in human cerebrospinal fluid
Q50553351The lrrk2 p.Gly2019Ser mutation is uncommon in a Danish cohort with various neurodegenerative disorders.
Q84258757The utility of EMG interference pattern analysis in botulinum toxin treatment of torticollis: a randomised, controlled and blinded study
Q77349095[Microdialysis. A method for measurement of local tissue metabolism]
Q74569654[Neurogenic bladder disturbances]

Search more.